Cardiovascular composition containing benzenediol derivatives

Abstract From the Canadian patent

There is described a mixture of 4-2-(6-(2-phenylethylamino)hexylamino)ethyl-1,2-benzenediol or, 4-2-(6-(2-chlorophenyl)ethylamino)hexylamino)ethyl-1,2benzenediol or a pharmaceutically acceptable acid addition salt of either thereof or as active ingredient and a, physiologically acceptable acid. There is also described a method of preparing a solid form of the active ingredient, which comprises freeze drying an aqueous solution of the mixture and a freeze, dried composition containing the active ingredient prepared by the method. The mixtures are useful as pharmaceuticals e.g. in, the treatment of cardiovascular conditions.